Improved Control of Tyrosine Kinase Inhibitor-Induced Diarrhea with a Novel Chloride Channel Modulator: A Case Report

Despite the efficacy of tyrosine kinase inhibitors (TKIs) across multiple cancers, side effects including treatment-related diarrhea can impede a patient’s ability to reach therapeutic doses or stay on therapy. Below, we present the case of a 72-year-old patient with metastatic papillary renal cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Greene, Claire, Barlesi, Brigid, Tarroza-David, Sigrid, Friedlander, Terence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140018/
https://www.ncbi.nlm.nih.gov/pubmed/33826111
http://dx.doi.org/10.1007/s40487-021-00147-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140018/
https://www.ncbi.nlm.nih.gov/pubmed/33826111
http://dx.doi.org/10.1007/s40487-021-00147-3

Ejemplares similares